MANE
Veradermics, IncorporatedNYSEHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.94B
P/E Ratio
—
EPS
$-2.64
Beta
—
52W High
$117.71
52W Low
$32.00
50-Day MA
$90.45
200-Day MA
$72.92
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Veradermics, Incorporated
Veradermics, Incorporated is a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company is headquartered in New Haven, Connecticut.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -72.10% |
| Return on Assets | -43.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $10.46 |
| Price-to-Book | 10.10 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $41.78M |
| Float | $27.21M |
| % Insiders | 2.74% |
| % Institutions | 79.58% |
Historical Volatility
HV 10-Day
71.61%
HV 20-Day
60.06%
HV 30-Day
61.02%
HV 60-Day
109.40%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($132.25 target)
4
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026